Roykar Pharmaceuticals Private Limited
About Roykar Pharmaceuticals Private Limited
Data last updated:
Roykar Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 15 July 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24232PN2015PTC155790. Its GSTIN is 27AAHCR4204M1Z7 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rupali Narayanrao Bobde and Rupesh Narayanrao Bobade.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 302 A Wing Aaditva Apt Indrayani Nagar Bhosari, Pune, Maharashtra, India – 411026.
As per the financials filed for FY 2025, the company reported a revenue of ₹97,800, a decline of 71% compared to the previous year. For the same year it recorded a net loss of ₹79,500 (net margin -81.3%) and EBITDA of -₹78,900 (EBITDA margin -80.7%). Revenue has declined at a compounded annual rate (CAGR) of 46% over three years and 33% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Roykar Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressA – 302 A Wing Aaditva Apt Indrayani Nagar Bhosari, Pune, Maharashtra, India – 411026
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Roykar Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Roykar Pharmaceuticals is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Roykar Pharmaceuticals Private Limited, buy the company report.
Financials of Roykar Pharmaceuticals Private Limited
FY 2025 filings availableRoykar Pharmaceuticals Private Limited reported revenue of ₹97,800 (down 71% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 33% over five years, including a 71% fall in the latest year. EBITDA rose 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹78,900 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹79,500 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -80.7% | ||||
| Net Profit Margin | -81.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Roykar Pharmaceuticals Private Limited, buy the company report.
Board of directors of Roykar Pharmaceuticals Private Limited
Roykar Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rupali Narayanrao Bobde | Director | 15 Jul 2015 | 11 Years 3 Months | Current |
| Rupesh Narayanrao Bobade | Director | 15 Jul 2015 | 11 Years 3 Months | Current |
Auditor
Roykar Pharmaceuticals Private Limited is audited by K B B & Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K B B & Associates | FY 2017 | 135391W |
Shareholding
The shareholding of Roykar Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Roykar Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Roykar Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Roykar Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Roykar Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCR4204M1Z7 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Roykar Pharmaceuticals Private Limited, buy the company report.
Recent activity
Roykar Pharmaceuticals Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Rupali Narayanrao Bobde was appointed as Director on 15 Jul 2015.
Frequently asked questions
Roykar Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in other wholesale, within the trading industry. It was incorporated on 15 July 2015 (11+ years old) and is registered under CIN U24232PN2015PTC155790.
Roykar Pharmaceuticals has 2 current directors:
- Rupali Narayanrao Bobde - Director
- Rupesh Narayanrao Bobade - Director
The latest financial statements of Roykar Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Roykar Pharmaceuticals is 27AAHCR4204M1Z7, registered in Maharashtra.
The CIN (Corporate Identification Number) of Roykar Pharmaceuticals is U24232PN2015PTC155790. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Roykar Pharmaceuticals was incorporated on 15 July 2015, making it 11+ years old. It is registered with the Registrar of Companies, Pune.
Rupali Narayanrao Bobde was appointed as Director on 15 Jul 2015. Rupesh Narayanrao Bobade was appointed as Director on 15 Jul 2015.
The registered office of Roykar Pharmaceuticals is at A – 302 A Wing Aaditva Apt Indrayani Nagar Bhosari, Pune, Maharashtra, India – 411026.
Roykar Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Roykar Pharmaceuticals is compliant as of 15 July 2026. The company is actively filing with the Registrar of Companies.